Results of Scheme Meeting: Offer by Natco Pharma to acquire all the remaining ordinary shares In Adcock Ingram ADCOCK INGRAM HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (Registration number: 2007/016236/06) JSE Ordinary Share code: AIP ISIN: ZAE000123436 ("Adcock Ingram" or "the Company") RESULTS OF GENERAL MEETING RELATING TO THE OFFER BY NATCO PHARMA TO ACQUIRE ALL THE REMAINING ORDINARY SHARES IN ADCOCK INGRAM BY WAY OF A SCHEME OF ARRANGEMENT Shareholders are referred to: - the firm intention announcement released on SENS on 23 July 2025 in relation to the proposed acquisition by Natco Pharma South Africa of all of the issued ordinary shares in Adcock Ingram other than those not already held by Natco, those currently owned by Bidvest and treasury shares of Adcock Ingram; - the circular to shareholders of Adcock Ingram dated 9 September 2025 (the "Circular"), incorporating a notice convening the general meeting; and - unless otherwise defined in this announcement, words and expressions contained herein shall have the same meanings as assigned to them in the Circular. 1. GENERAL MEETING RESULTS The General Meeting was held on 9 October 2025 at 1pm South African Standard Time by way of in person / electronic participation. The Scheme Resolution required to approve the Scheme, in terms of sections 114 and 115 of the Companies Act, was tabled and put to vote. The results of voting were as follows: Resolution For Against Number of Shares voted disclosed Shares abstained Shares Voted as a % of total issued disclosed as a % of shares entitled to be the total issue voted in respect of the shares entitled to Scheme Resolution be voted in respect of the Scheme Resolution Scheme Resolution in 98.66% 1.34% 36,825,684 73.16(1) 0.01%(1) accordance with sections 114(1)(c) and 115(2)(a) of the Companies Act (1) Total number of Ordinary Shares in issue as at Friday, 3 October 2025, being the Voting Record Date was 50,351,444 excluding the Excluded Shares. The Scheme Resolution was therefore passed by the requisite majority of votes exercised at the General Meeting. The quorum requirements were satisfied in accordance with the Companies Act and the Company's MOI. 2. CONDITIONS AND IMPLEMENTATION The Scheme remains subject to the fulfilment or waiver of the outstanding conditions precedent set out in the Circular. Once the Scheme becomes unconditional and the TRP has issued a compliance certificate, the issued ordinary shares of Adcock Ingram will be delisted from the Main Board of the JSE Limited in terms of paragraph 1.17(b) of the JSE Listings Requirements and the Adcock Ingram Shareholders recorded on the Adcock Ingram Securities Register on the Scheme Record Date will receive the Per Share Scheme Consideration of R75.00 per Adcock Ingram Share. The final salient dates for the implementation of the Scheme and delisting of Adcock Ingram from the JSE will be announced in due course. 3. RESPONSIBILITY STATEMENT The Adcock Ingram Board and Adcock Ingram Independent Board collectively and individually accepts responsibility for the information contained in this announcement insofar as it relates to the Company, and certifies that, to the best of its knowledge and belief, such information contained herein is true and nothing has been omitted which is likely to affect the import of such information. Midrand 10 October 2025 Financial Advisor to the Company Goldman Sachs International Legal Advisor to the Company Edward Nathan Sonnenbergs Inc. JSE Equity Sponsor to the Company Rand Merchant Bank (A division of FirstRand Bank Limited) Independent Expert BDO Corporate Finance Proprietary Limited Financial Advisor to the Offeror Investec Bank Limited Legal Advisor to the Offeror Bowmans Legal Advisor to Bidvest Alchemy Law Date: 10-10-2025 07:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.